Biometric UPI Transactions Cross 600 Million Mark in June, Reach Rs 25,416 Crore in Value

New Delhi, July 8: Biometric authentication-based Unified Payments Interface (UPI) transactions recorded significant growth in June, crossing 600 million transactions with a total value of Rs 25,416 crore.

The rise in biometric-enabled UPI payments reflects the growing acceptance of secure and convenient digital payment methods among users across the country. Fingerprint-based authentication has helped make digital transactions easier and more accessible, particularly for people in rural and remote areas.

The increase in transaction numbers highlights the expanding reach of India’s digital payment ecosystem and the growing trust among users in technology-driven financial services. Biometric authentication has emerged as an important tool in promoting financial inclusion by enabling smoother access to banking and payment facilities.

Officials said the continued growth of biometric UPI transactions is a sign of increasing adoption of cashless payment solutions. The system is expected to further strengthen secure and user-friendly digital transactions as more people embrace digital financial services.

The latest milestone reflects the rapid evolution of India’s digital economy and the efforts to create a more inclusive and accessible payment ecosystem for citizens.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

  • Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia

    Milan, Italy, July 08 — Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), has today announced the publication of preclinical data supporting the potential of its liver-directed immune-shielded lentiviral gene therapy approach to treat methylmalonic acidemia (MMA), a severe inherited metabolic disorder. The findings, published in the Journal of Hepatology, show that a single systemic administration of a lentiviral vector encoding the MMUT gene led to sustained improvements in disease features in a validated mouse model of MMA, with effects lasting for the average lifespan of laboratory mice. Since the mice were treated when young, the study supports the durability of the gene therapy through postnatal growth and maturation of the liver. MMA is caused by a deficiency of methylmalonyl-CoA mutase, an enzyme that plays a critical role in the body’s metabolism of food. Its absence results in the accumulation of toxic metabolites that lead to recurrent metabolic crises, growth failure, neurological impairment, and multi-organ damage. In the study, researchers also treated mice with a dose containing an optimized MMUT transgene, thereby improving therapeutic efficacy. In the same mouse model of MMA, this…

    Read More

  • High-Energy Punjabi Party Anthem ‘Naachi Jaave’ Is Here

    Mumbai , July 8: The wait for this season’s ultimate party track is finally over. Tips Music has released its brand-new Punjabi single ‘Naachi Jaave‘,…

    Read More

  • Poshan Tracker Achieves Milestone with 8.93 Crore Beneficiary Coverage

    New Delhi, July 8: The Poshan Tracker platform has achieved a major milestone by recording 8.93 crore beneficiaries across the…

    Read More